“Lebrikizumab Monotherapy Reduces Flares in Patients With Moderate-to-Severe Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine 7, no. 2 (March 13, 2023): s147. Accessed April 18, 2025. https://skin.dermsquared.com/skin/article/view/1949.